• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺液和精液中丝氨酸蛋白酶前列腺特异性抗原对补体因子 iC3b 和 C5 的蛋白水解作用。

Proteolysis of complement factors iC3b and C5 by the serine protease prostate-specific antigen in prostatic fluid and seminal plasma.

机构信息

Department of Pharmacology and Molecular Sciences, The Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.

出版信息

J Immunol. 2013 Mar 15;190(6):2567-74. doi: 10.4049/jimmunol.1200856. Epub 2013 Feb 11.

DOI:10.4049/jimmunol.1200856
PMID:23401592
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4038161/
Abstract

Prostate-specific Ag (PSA) is a serine protease that is expressed exclusively by normal and malignant prostate epithelial cells. The continued high-level expression of PSA by the majority of men with both high- and low-grade prostate cancer throughout the course of disease progression, even in the androgen-ablated state, suggests that PSA has a role in the pathogenesis of disease. Current experimental and clinical evidence suggests that chronic inflammation, regardless of the cause, may predispose men to prostate cancer. The responsibility of the immune system in immune surveillance and eventually tumor progression is well appreciated but not completely understood. In this study, we used a mass spectrometry-based evaluation of prostatic fluid obtained from diseased prostates after removal by radical prostatectomy to identify potential immunoregulatory proteins. This analysis revealed the presence of Igs and the complement system proteins C3, factor B, and clusterin. Verification of these findings by Western blot confirmed the high-level expression of C3 in the prostatic fluid and the presence of a previously uncharacterized C-terminal C3 cleavage product. Biochemical analysis of this C3 cleavage fragment revealed a putative PSA cleavage site after tyrosine-1348. Purified PSA was able to cleave iC3b and the related complement protein C5. These results suggest a previously uncharacterized function of PSA as an immunoregulatory protease that could help to create an environment hospitable to malignancy through proteolysis of the complement system.

摘要

前列腺特异性抗原(PSA)是一种丝氨酸蛋白酶,仅在正常和恶性前列腺上皮细胞中表达。大多数患有高级别和低级别前列腺癌的男性在疾病进展过程中,甚至在去雄激素状态下,PSA 的高水平表达持续存在,这表明 PSA 在疾病发病机制中起作用。目前的实验和临床证据表明,慢性炎症(无论其原因如何)可能使男性更容易患上前列腺癌。免疫系统在免疫监视和最终肿瘤进展中的作用得到了充分的认识,但尚未完全理解。在这项研究中,我们使用基于质谱的方法评估了根治性前列腺切除术后切除的患病前列腺中的前列腺液,以鉴定潜在的免疫调节蛋白。该分析显示存在 Ig 和补体系统蛋白 C3、因子 B 和簇蛋白。Western blot 对这些发现的验证证实了 C3 在前列腺液中的高水平表达以及存在以前未表征的 C 端 C3 切割产物。对该 C3 切割片段的生化分析揭示了在酪氨酸-1348 后存在潜在的 PSA 切割位点。纯化的 PSA 能够切割 iC3b 和相关的补体蛋白 C5。这些结果表明 PSA 具有以前未表征的免疫调节蛋白酶功能,通过对补体系统的蛋白水解作用,可能有助于创造有利于恶性肿瘤的环境。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25a0/4038161/790ff93e082a/nihms-503136-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25a0/4038161/fd0ad08508ef/nihms-503136-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25a0/4038161/0c1ecebc1afd/nihms-503136-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25a0/4038161/71f6a00077f7/nihms-503136-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25a0/4038161/7f9f8a2d201c/nihms-503136-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25a0/4038161/909006a0ec35/nihms-503136-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25a0/4038161/19b853eed74d/nihms-503136-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25a0/4038161/790ff93e082a/nihms-503136-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25a0/4038161/fd0ad08508ef/nihms-503136-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25a0/4038161/0c1ecebc1afd/nihms-503136-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25a0/4038161/71f6a00077f7/nihms-503136-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25a0/4038161/7f9f8a2d201c/nihms-503136-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25a0/4038161/909006a0ec35/nihms-503136-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25a0/4038161/19b853eed74d/nihms-503136-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25a0/4038161/790ff93e082a/nihms-503136-f0007.jpg

相似文献

1
Proteolysis of complement factors iC3b and C5 by the serine protease prostate-specific antigen in prostatic fluid and seminal plasma.前列腺液和精液中丝氨酸蛋白酶前列腺特异性抗原对补体因子 iC3b 和 C5 的蛋白水解作用。
J Immunol. 2013 Mar 15;190(6):2567-74. doi: 10.4049/jimmunol.1200856. Epub 2013 Feb 11.
2
EspP, a serine protease of enterohemorrhagic Escherichia coli, impairs complement activation by cleaving complement factors C3/C3b and C5.肠出血性大肠杆菌的丝氨酸蛋白酶 EspP 通过切割补体因子 C3/C3b 和 C5 来破坏补体激活。
Infect Immun. 2010 Oct;78(10):4294-301. doi: 10.1128/IAI.00488-10. Epub 2010 Jul 19.
3
Biology of prostate-specific antigen.前列腺特异性抗原的生物学
J Clin Oncol. 2003 Jan 15;21(2):383-91. doi: 10.1200/JCO.2003.02.083.
4
Galectin-3 is a substrate for prostate specific antigen (PSA) in human seminal plasma.半乳糖凝集素-3 是人精液前列腺特异性抗原(PSA)的底物。
Prostate. 2011 Feb 1;71(2):197-208. doi: 10.1002/pros.21236.
5
Seminal fluid characterization for male fertility and prostate cancer: kallikrein-related serine proteases and whole proteome approaches.用于男性生育力和前列腺癌的精液特征分析:激肽释放酶相关丝氨酸蛋白酶和全蛋白质组方法
Semin Thromb Hemost. 2007 Feb;33(1):87-99. doi: 10.1055/s-2006-958467.
6
Acid-activated insulin-like growth factor binding protein protease activity of cathepsin D in normal and malignant prostatic epithelial cells and seminal plasma.组织蛋白酶D在正常及恶性前列腺上皮细胞和精浆中的酸激活胰岛素样生长因子结合蛋白蛋白酶活性
J Cell Physiol. 1997 May;171(2):196-204. doi: 10.1002/(SICI)1097-4652(199705)171:2<196::AID-JCP10>3.0.CO;2-C.
7
Prostate-specific antigen and human glandular kallikrein: two kallikreins of the human prostate.
Ann Med. 1994 Jun;26(3):157-64. doi: 10.3109/07853899409147884.
8
Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65.表达裂解C3的膜蛋白酶p65的人黑色素瘤细胞补体抗性的分子基础
Cancer Res. 1993 Feb 1;53(3):592-9.
9
Crystal structure of human prostate-specific antigen in a sandwich antibody complex.人前列腺特异性抗原在三明治抗体复合物中的晶体结构。
J Mol Biol. 2011 Dec 9;414(4):530-44. doi: 10.1016/j.jmb.2011.10.007. Epub 2011 Oct 20.
10
Old dogs-new tricks: immunoregulatory properties of C3 and C5 cleavage fragments.老狗新把戏:C3 和 C5 裂解片段的免疫调节特性。
Immunol Rev. 2016 Nov;274(1):112-126. doi: 10.1111/imr.12473.

引用本文的文献

1
KLK15 alters connective tissues in hypermobile Ehlers-Danlos syndrome.激肽释放酶15改变了可活动过度型埃勒斯-当洛综合征中的结缔组织。
iScience. 2025 Aug 12;28(9):113343. doi: 10.1016/j.isci.2025.113343. eCollection 2025 Sep 19.
2
Non-canonical extracellular complement pathways and the complosome paradigm in cancer: a scoping review.癌症中的非经典细胞外补体途径与补体体范式:一项范围综述
Front Immunol. 2025 Apr 30;16:1519465. doi: 10.3389/fimmu.2025.1519465. eCollection 2025.
3
Distinct mesenchymal cell states mediate prostate cancer progression.

本文引用的文献

1
Unique structure of iC3b resolved at a resolution of 24 Å by 3D-electron microscopy.通过三维电子显微镜以 24Å 的分辨率解析 iC3b 的独特结构。
Proc Natl Acad Sci U S A. 2011 Aug 9;108(32):13236-40. doi: 10.1073/pnas.1106746108. Epub 2011 Jul 25.
2
Enzymatically active prostate-specific antigen promotes growth of human prostate cancers.具有酶活性的前列腺特异性抗原促进人类前列腺癌的生长。
Prostate. 2011 Nov;71(15):1595-607. doi: 10.1002/pros.21375. Epub 2011 Mar 10.
3
History of the term prostate.“前列腺”一词的历史。
不同的间充质细胞状态介导前列腺癌的进展。
Nat Commun. 2024 Jan 8;15(1):363. doi: 10.1038/s41467-023-44210-1.
4
The Blood-prostate Barrier: An Obstacle to Drug Delivery into the Prostate.血-前列腺屏障:药物输送至前列腺的障碍。
Curr Drug Deliv. 2025;22(4):401-412. doi: 10.2174/1567201821666230807152520.
5
Inflammatory response to Trichomonas vaginalis in the pathogenesis of prostatitis and benign prostatic hyperplasia.滴虫感染引起的前列腺炎和良性前列腺增生的炎症反应。
Parasites Hosts Dis. 2023 Feb;61(1):2-14. doi: 10.3347/PHD.22160. Epub 2023 Feb 22.
6
Remodelling of the tumour microenvironment by the kallikrein-related peptidases.激肽释放酶相关肽酶重塑肿瘤微环境。
Nat Rev Cancer. 2022 Apr;22(4):223-238. doi: 10.1038/s41568-021-00436-z. Epub 2022 Jan 31.
7
Role of Complement in Regulating Inflammation Processes in Renal and Prostate Cancers.补体在调控肾和前列腺癌炎症过程中的作用。
Cells. 2021 Sep 15;10(9):2426. doi: 10.3390/cells10092426.
8
Complement opsonization of nanoparticles: Differences between humans and preclinical species.纳米颗粒的补体调理:人类与临床前物种的差异。
J Control Release. 2021 Oct 10;338:548-556. doi: 10.1016/j.jconrel.2021.08.048. Epub 2021 Sep 2.
9
Complement and Cancer-A Dysfunctional Relationship?补体与癌症——一种功能失调的关系?
Antibodies (Basel). 2020 Nov 5;9(4):61. doi: 10.3390/antib9040061.
10
Context-dependent roles of complement in cancer.补体在癌症中的语境相关作用。
Nat Rev Cancer. 2019 Dec;19(12):698-715. doi: 10.1038/s41568-019-0210-0. Epub 2019 Oct 30.
Prostate. 2009 Feb 1;69(2):208-13. doi: 10.1002/pros.20871.
4
Potent and selective peptidyl boronic acid inhibitors of the serine protease prostate-specific antigen.丝氨酸蛋白酶前列腺特异性抗原的强效和选择性肽基硼酸抑制剂。
Chem Biol. 2008 Jul 21;15(7):665-74. doi: 10.1016/j.chembiol.2008.05.020.
5
Cytokine profiling of prostatic fluid from cancerous prostate glands identifies cytokines associated with extent of tumor and inflammation.对来自癌性前列腺的前列腺液进行细胞因子分析,可确定与肿瘤程度和炎症相关的细胞因子。
Prostate. 2008 Jun 1;68(8):872-82. doi: 10.1002/pros.20755.
6
Measurements of phagocytosis and phagosomal maturation.吞噬作用和吞噬体成熟的测量。
Curr Protoc Cell Biol. 2004 May;Chapter 15:Unit 15.7. doi: 10.1002/0471143030.cb1507s22.
7
Macrophage complement receptors and pathogen clearance.巨噬细胞补体受体与病原体清除
Cell Microbiol. 2007 Sep;9(9):2095-102. doi: 10.1111/j.1462-5822.2007.00981.x. Epub 2007 Jun 21.
8
Inflammation in prostate carcinogenesis.前列腺癌发生过程中的炎症
Nat Rev Cancer. 2007 Apr;7(4):256-69. doi: 10.1038/nrc2090.
9
Structural transitions of complement component C3 and its activation products.补体成分C3及其激活产物的结构转变
Proc Natl Acad Sci U S A. 2006 Dec 26;103(52):19737-42. doi: 10.1073/pnas.0609791104. Epub 2006 Dec 15.
10
Does PSA play a role as a promoting agent during the initiation and/or progression of prostate cancer?前列腺特异性抗原(PSA)在前列腺癌的起始和/或进展过程中是否起到促进作用?
Prostate. 2007 Feb 15;67(3):312-29. doi: 10.1002/pros.20531.